CIK 0001635088 · Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- operating
- EIN
- 981173944
- Phone
- 441-295-5950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- 4 Other disposition President and Vant Chair disposed of 1,176,143 shares (other)
- 4 Other disposition CEO disposed of 156,307 shares (other)
- 4 Other disposition President & CIO disposed of 165,444 shares (other)
- 4 Open-market sale CFO sold 300,000 shares at an average $41.58 ($12,473,272)
- 4 Planned sale President & Immunovant CEO sold 187,943 shares at an average $40.53 ($7,617,074)
- 4 Planned sale President & Immunovant CEO sold 200,000 shares at $36.31 ($7,262,000)
- 4 Planned sale President & Immunovant CEO sold 200,000 shares at $36.59 ($7,318,000)
- 4 Grant or award Director acquired 810 shares (grant or award)
- 4 Shares withheld for taxes Director gave up 116 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 77 shares (to pay taxes)
- 4 Planned sale President & Immunovant CEO sold 200,000 shares at an average $35.11 ($7,022,668)
- 4 Shares withheld for taxes President & CIO gave up 19,976 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 34,638 shares (to pay taxes)
- 4 Returned to the company Director returned 8,967,383 shares (to the company)
- 4 Planned sale Director sold 17,750 shares at an average $36.10 ($640,861)
- 4 Shares withheld for taxes CEO gave up 76,171 shares (to pay taxes)
- 4 Shares withheld for taxes President and Vant Chair gave up 40,309 shares (to pay taxes)
- 4 Shares withheld for taxes President & CIO gave up 46,879 shares (to pay taxes)
- 4 Planned sale President & Immunovant CEO sold 200,000 shares at $36.62 ($7,324,000)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 3,880 shares (to pay taxes)
Page 1 of 26 · 511 filings